Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.
Identifieur interne : 000F18 ( PubMed/Corpus ); précédent : 000F17; suivant : 000F19Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.
Auteurs : Silvio Taschieri ; Stefano Corbella ; Massimo Del FabbroSource :
- The Journal of oral implantology [ 0160-6972 ] ; 2012.
English descriptors
- KwdEn :
- Adult, Aged, Alveolar Bone Loss (surgery), Alveolar Bone Loss (therapy), Alveolar Ridge Augmentation (methods), Biological Dressings, Female, Growth Substances (administration & dosage), Growth Substances (isolation & purification), Growth Substances (physiology), Humans, Intercellular Signaling Peptides and Proteins (administration & dosage), Intercellular Signaling Peptides and Proteins (isolation & purification), Jaw, Edentulous (rehabilitation), Jaw, Edentulous (surgery), Male, Maxilla (surgery), Maxillary Sinus (surgery), Middle Aged, Nasal Mucosa (injuries), Nasal Mucosa (physiology), Oral Surgical Procedures, Preprosthetic (methods), Pilot Projects, Platelet-Rich Plasma (chemistry), Platelet-Rich Plasma (physiology), Prospective Studies, Sinus Floor Augmentation (methods), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Growth Substances, Intercellular Signaling Peptides and Proteins.
- chemical , isolation & purification : Growth Substances, Intercellular Signaling Peptides and Proteins.
- chemistry : Platelet-Rich Plasma.
- injuries : Nasal Mucosa.
- methods : Alveolar Ridge Augmentation, Oral Surgical Procedures, Preprosthetic, Sinus Floor Augmentation.
- chemical , physiology : Growth Substances, Nasal Mucosa, Platelet-Rich Plasma.
- rehabilitation : Jaw, Edentulous.
- surgery : Alveolar Bone Loss, Jaw, Edentulous, Maxilla, Maxillary Sinus.
- therapy : Alveolar Bone Loss.
- Adult, Aged, Biological Dressings, Female, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Treatment Outcome.
Abstract
The aim of this pilot study was to present a novel technique for the management of the Schneiderian membrane during maxillary sinus lift surgery using plasma rich in growth factors (PRGF). Eight maxillary sinuses were augmented in 8 patients. Two small perforations of the Schneiderian membrane occurred during the lifting procedure, which were solved using the PRGF clot before grafting the site with PRGF and anorganic bovine bone. With the exception of 1 patient who experienced pain following an acute sinus infection after 3 days of uneventful healing, the patients' postoperative quality of life was generally good. The most common complication (50% of cases) was hematoma, which disappeared after 1 week. Despite the limitations of this study concerning the sample size and the study design, the use of PRGF may be helpful in reducing complications following sinus lift surgery. More well-designed studies, with larger sample size, are needed to validate this protocol.
DOI: 10.1563/AAID-JOI-D-12-00009
PubMed: 23072223
Links to Exploration step
pubmed:23072223Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.</title><author><name sortKey="Taschieri, Silvio" sort="Taschieri, Silvio" uniqKey="Taschieri S" first="Silvio" last="Taschieri">Silvio Taschieri</name><affiliation><nlm:affiliation>Università degli Studi di Milano, Department of Health Technologies, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Corbella, Stefano" sort="Corbella, Stefano" uniqKey="Corbella S" first="Stefano" last="Corbella">Stefano Corbella</name></author><author><name sortKey="Del Fabbro, Massimo" sort="Del Fabbro, Massimo" uniqKey="Del Fabbro M" first="Massimo" last="Del Fabbro">Massimo Del Fabbro</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23072223</idno><idno type="pmid">23072223</idno><idno type="doi">10.1563/AAID-JOI-D-12-00009</idno><idno type="wicri:Area/PubMed/Corpus">000F18</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.</title><author><name sortKey="Taschieri, Silvio" sort="Taschieri, Silvio" uniqKey="Taschieri S" first="Silvio" last="Taschieri">Silvio Taschieri</name><affiliation><nlm:affiliation>Università degli Studi di Milano, Department of Health Technologies, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Corbella, Stefano" sort="Corbella, Stefano" uniqKey="Corbella S" first="Stefano" last="Corbella">Stefano Corbella</name></author><author><name sortKey="Del Fabbro, Massimo" sort="Del Fabbro, Massimo" uniqKey="Del Fabbro M" first="Massimo" last="Del Fabbro">Massimo Del Fabbro</name></author></analytic><series><title level="j">The Journal of oral implantology</title><idno type="ISSN">0160-6972</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Alveolar Bone Loss (surgery)</term><term>Alveolar Bone Loss (therapy)</term><term>Alveolar Ridge Augmentation (methods)</term><term>Biological Dressings</term><term>Female</term><term>Growth Substances (administration & dosage)</term><term>Growth Substances (isolation & purification)</term><term>Growth Substances (physiology)</term><term>Humans</term><term>Intercellular Signaling Peptides and Proteins (administration & dosage)</term><term>Intercellular Signaling Peptides and Proteins (isolation & purification)</term><term>Jaw, Edentulous (rehabilitation)</term><term>Jaw, Edentulous (surgery)</term><term>Male</term><term>Maxilla (surgery)</term><term>Maxillary Sinus (surgery)</term><term>Middle Aged</term><term>Nasal Mucosa (injuries)</term><term>Nasal Mucosa (physiology)</term><term>Oral Surgical Procedures, Preprosthetic (methods)</term><term>Pilot Projects</term><term>Platelet-Rich Plasma (chemistry)</term><term>Platelet-Rich Plasma (physiology)</term><term>Prospective Studies</term><term>Sinus Floor Augmentation (methods)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Growth Substances</term><term>Intercellular Signaling Peptides and Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Growth Substances</term><term>Intercellular Signaling Peptides and Proteins</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Platelet-Rich Plasma</term></keywords><keywords scheme="MESH" qualifier="injuries" xml:lang="en"><term>Nasal Mucosa</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Alveolar Ridge Augmentation</term><term>Oral Surgical Procedures, Preprosthetic</term><term>Sinus Floor Augmentation</term></keywords><keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Growth Substances</term><term>Nasal Mucosa</term><term>Platelet-Rich Plasma</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Jaw, Edentulous</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Alveolar Bone Loss</term><term>Jaw, Edentulous</term><term>Maxilla</term><term>Maxillary Sinus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Alveolar Bone Loss</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Biological Dressings</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this pilot study was to present a novel technique for the management of the Schneiderian membrane during maxillary sinus lift surgery using plasma rich in growth factors (PRGF). Eight maxillary sinuses were augmented in 8 patients. Two small perforations of the Schneiderian membrane occurred during the lifting procedure, which were solved using the PRGF clot before grafting the site with PRGF and anorganic bovine bone. With the exception of 1 patient who experienced pain following an acute sinus infection after 3 days of uneventful healing, the patients' postoperative quality of life was generally good. The most common complication (50% of cases) was hematoma, which disappeared after 1 week. Despite the limitations of this study concerning the sample size and the study design, the use of PRGF may be helpful in reducing complications following sinus lift surgery. More well-designed studies, with larger sample size, are needed to validate this protocol.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23072223</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2012</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6972</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of oral implantology</Title><ISOAbbreviation>J Oral Implantol</ISOAbbreviation></Journal><ArticleTitle>Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.</ArticleTitle><Pagination><MedlinePgn>621-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1563/AAID-JOI-D-12-00009</ELocationID><Abstract><AbstractText>The aim of this pilot study was to present a novel technique for the management of the Schneiderian membrane during maxillary sinus lift surgery using plasma rich in growth factors (PRGF). Eight maxillary sinuses were augmented in 8 patients. Two small perforations of the Schneiderian membrane occurred during the lifting procedure, which were solved using the PRGF clot before grafting the site with PRGF and anorganic bovine bone. With the exception of 1 patient who experienced pain following an acute sinus infection after 3 days of uneventful healing, the patients' postoperative quality of life was generally good. The most common complication (50% of cases) was hematoma, which disappeared after 1 week. Despite the limitations of this study concerning the sample size and the study design, the use of PRGF may be helpful in reducing complications following sinus lift surgery. More well-designed studies, with larger sample size, are needed to validate this protocol.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taschieri</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Università degli Studi di Milano, Department of Health Technologies, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbella</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Del Fabbro</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Oral Implantol</MedlineTA><NlmUniqueID>7801086</NlmUniqueID><ISSNLinking>0160-6972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006133">Growth Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016301" MajorTopicYN="N">Alveolar Bone Loss</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000540" MajorTopicYN="N">Alveolar Ridge Augmentation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001684" MajorTopicYN="Y">Biological Dressings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006133" MajorTopicYN="N">Growth Substances</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036341" MajorTopicYN="N">Intercellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007575" MajorTopicYN="N">Jaw, Edentulous</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008437" MajorTopicYN="N">Maxilla</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008443" MajorTopicYN="N">Maxillary Sinus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009297" MajorTopicYN="N">Nasal Mucosa</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013516" MajorTopicYN="N">Oral Surgical Procedures, Preprosthetic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053657" MajorTopicYN="N">Platelet-Rich Plasma</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059546" MajorTopicYN="N">Sinus Floor Augmentation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23072223</ArticleId><ArticleId IdType="doi">10.1563/AAID-JOI-D-12-00009</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23072223
|texte= Use of plasma rich in growth factor for schneiderian membrane management during maxillary sinus augmentation procedure.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23072223" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |